Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CT Body Composition Predicts Supervised Exercise Response in Peripheral Arterial Disease: A Protocol

NCT07433309 is registered in ClinicalTrials.gov with Nemocnice AGEL Trinec-Podlesi a.s. as lead sponsor.

NCT NCT07433309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07433309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CT Body Composition Predicts Supervised Exercise Response in Peripheral Arterial Disease: A Protocol
Lead sponsor
Nemocnice AGEL Trinec-Podlesi a.s.
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
January 31, 2031
Enrollment
128 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

body composition, peripheral arterial disease, sarcopenia, sarcopenic obesity